6:59 PM · 15 March 2022

Eli Lilly suspends majority of activities in Russia

Eli Lilly (LLY.US) announced today it will suspend all investments, promotional activities and export of non-essential medicines to Russia. Also the company does not plan to start new clinical studies in the country. Drugmaker will still provide medication for patients who suffer from cancer and diabetes, however will donate all profits from ongoing Russian operations for humanitarian purposes. Other drugmakers and medical device makers took similar approaches pointing to international humanitarian law under which they are responsible to continue supplying medicines to the country.

Eli Lilly (LLY.US) stock price suffered a downward correction at the beginning of the year, however buyers managed to halt declines around support at $232.00, which is marked with a lower limit of the 1:1 structure. Next buyers took the initiative and price broke above the local resistance at $247.20 which coincides with 50 SMA (green line), 200 SMA (red line) and 23.6% Fibonacci retracement of the upward wave launched in October 2020. If current sentiment prevails, upward move may accelerate towards all-time high around $285.00. Source: xStation5

28 August 2026, 2:54 PM

US Open: Wall Street rises ahead of Fed Chair’s Jackson Hole speech 🚩 Marvell Technology and PayPal decline

28 August 2026, 12:27 PM

Market Wrap: A mild breeze of optimism ahead of Jackson Hole

27 August 2026, 7:10 PM

Daily Summary: Nvidia drives the Nasdaq 100 up 1.3% (27.08.2026)

27 August 2026, 4:55 PM

US Open: Nvidia breaks the curse – 7% gain drives the Nasdaq! (27.08.2026)

The financial instruments we offer, especially CFDs, can be highly risky. Fractional Shares (FS) is an acquired from XTB fiduciary right to fractional parts of stocks and ETFs. FS are not a separate financial instrument. The limited corporate rights are associated with FS.
This page was not created for investors residing in Brazil. This brokerage is not authorized by the Comissão de Valores Mobiliários (CVM) or the Brazilian Central Bank (BCB). The content of this page should not be characterized as an investment offer in Brazil or for investors residing in that country.
Losses can exceed deposits